Related Experiment Video

Updated: Aug 19, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

c-erbB-2/p185-directed therapy in human lung adenocarcinoma

J M Snider1, L J Bushnell, L C Chen

  • 1Division of Cardiothoracic Surgery, University of Iowa Hospitals and Clinics, Iowa City, USA.

The Annals of Thoracic Surgery
|November 1, 1996
PubMed
Abstract

Insights

Targeting lung adenocarcinoma with an anti-p185-gelonin conjugate effectively kills cancer cells. This novel therapy shows selective and potent cytotoxicity against p185-overexpressing cells in vitro.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunotherapy

Background:

  • c-erbB-2/p185 is overexpressed in approximately one-third of non-small cell lung cancers.
  • CALU-3, a human lung adenocarcinoma cell line, exhibits p185 overexpression.
  • The study investigates the therapeutic potential of targeting p185 in lung adenocarcinoma.

Purpose of the Study:

  • To evaluate the efficacy of an anti-p185-gelonin conjugate as a targeted therapy for lung adenocarcinoma.
  • To determine the in vitro cytotoxicity of the 4D5-gelonin conjugate against p185-overexpressing cancer cells.

Main Methods:

  • Covalent linkage of the anti-p185 monoclonal antibody (4D5) and the toxin gelonin.
  • Confirmation of conjugate purification using SDS-PAGE.
  • Quantification of dose-dependent cytotoxicity via 3H-thymidine uptake in CALU-3 cells.

Main Results:

  • The 4D5-gelonin conjugate demonstrated significant cytotoxicity with a 50% inhibitory concentration of 3.5 x 10(-10) mol/L.
  • Unconjugated 4D5 showed no cytotoxic effect, while gelonin and the mixture had significantly lower cytotoxicity.
  • The conjugate exhibited minimal toxicity against p185-negative NIH3T3 cells, indicating selectivity.

Conclusions:

  • Targeted therapy using the c-erbB-2/p185-directed anti-p185-gelonin conjugate achieves selective and efficient killing of human lung adenocarcinoma cells in vitro.
  • This approach holds promise for the treatment of lung adenocarcinomas overexpressing p185.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...